India’s pharmaceutical market demonstrated robust growth, climbing 8.1% in August, fueled by chronic treatments like cardiac and anti-diabetic drugs. Respiratory and cancer medications also saw strong demand. GLP-1 therapies experienced a remarkable 97% surge, significantly boosting anti-diabetic sales. Post navigation India Wealth Report 2025: Maharashtra leads with 1.78 lakh millionaires EU CBAM challenge: GTRI warns of trade hit; urges India to fast-track carbon scheme